(19)
(11) EP 2 589 386 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.08.2015 Bulletin 2015/35

(45) Mention of the grant of the patent:
17.06.2015 Bulletin 2015/25

(21) Application number: 11842457.1

(22) Date of filing: 21.12.2011
(51) International Patent Classification (IPC): 
A61K 31/52(2006.01)
A61P 27/10(2006.01)
 A61K 45/00(2006.01)
(86) International application number:
PCT/CN2011/084332
(87) International publication number:
WO 2012/089053 (05.07.2012 Gazette 2012/27)

(54)

METHOD FOR INHIBITING MYOPIA AND USE OF ADENYLATE CYCLASE INHIBITOR AS DRUG FOR INHIBITING MYOPIA

VERFAHREN ZUR HEMMUNG VON KURZSICHTIGKEIT UND VERWENDUNG DES ADENYLAT-CYCLASE-HEMMERS ALS HEILMITTEL ZUR HEMMUNG VON KURZSICHTIGKEIT

PROCÉDÉ DESTINÉ À EMPÊCHER LE DÉVELOPPEMENT DE LA MYOPIE, ET UTILISATION D'UN INHIBITEUR DE L'ADÉNYLCYCLASE EN TANT QUE MÉDICAMENT DESTINÉ À EMPÊCHER LE DÉVELOPPEMENT DE LA MYOPIE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 27.12.2010 CN 201010605133

(43) Date of publication of application:
08.05.2013 Bulletin 2013/19

(73) Proprietor: School of Ophthalmology & Optometry, Wenzhou Medical College
Wenzhou Zhejiang 325027 (CN)

(72) Inventors:
  • ZHOU, Xiangtian
    Wenzhou Zhejiang 325027 (CN)
  • QU, Jia
    Wenzhou Zhejiang 325027 (CN)
  • TAO, Yijin
    Wenzhou Zhejiang 325027 (CN)
  • PAN, Miaozhen
    Wenzhou Zhejiang 325027 (CN)

(74) Representative: Viering, Jentschura & Partner Patent- und Rechtsanwälte 
Kennedydamm 55 / Roßstrasse
40476 Düsseldorf
40476 Düsseldorf (DE)


(56) References cited: : 
WO-A1-2009/139511
CN-A- 102 078 614
 WO-A2-2010/126260
   
  • SHELTON LILIAN ET AL: "Inhibition of Human Scleral Fibroblast Cell Attachment to Collagen Type I by TGFBIp", IOVS, vol. 50, no. 8, August 2009 (2009-08), pages 3542-3552, XP002695740, ISSN: 0146-0404
  • ZHANG, WEIJUAN ET AL.: 'The effect of U73122 and SQ 22536 on the hyperplasia and TGF-p2 secretion of retinal pigment epithelium cells' CHINESE OPHTHALMIC RESEARCH vol. 28, no. 6, June 2010, pages 519 - 523
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).